Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 135

Similar articles for PubMed (Select 22967780)

1.

Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.

Cerimele JM, Durango A.

J Clin Psychiatry. 2012 Aug;73(8):e1039-47. doi: 10.4088/JCP.11r07410. Review.

PMID:
22967780
2.

A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.

Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP.

J Clin Psychiatry. 2012 May;73(5):654-60. doi: 10.4088/JCP.11m07522. Erratum in: J Clin Psychiatry. 2012 Jul;73(7):1035.

PMID:
22697191
3.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
4.

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.

Smith RC, Lindenmayer JP, Davis JM, Cornwell J, Noth K, Gupta S, Sershen H, Lajtha A.

Schizophr Res. 2009 May;110(1-3):149-55. doi: 10.1016/j.schres.2009.02.001. Epub 2009 Feb 28.

PMID:
19251401
5.

Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.

Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye A.

Arch Gen Psychiatry. 2011 Dec;68(12):1195-206. doi: 10.1001/archgenpsychiatry.2011.83. Epub 2011 Aug 1.

6.
7.

Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness.

Purvis TL, Mambourg SE, Balvanz TM, Magallon HE, Pham RH.

Ann Pharmacother. 2009 May;43(5):862-7. doi: 10.1345/aph.1L661. Epub 2009 Apr 21.

PMID:
19383936
8.

Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.

DiPaula BA, Thomas MD.

Pharmacotherapy. 2009 Jul;29(7):852-7. doi: 10.1592/phco.29.7.852.

PMID:
19558259
9.

Varenicline: aggression and homicidal ideation.

[No authors listed]

Prescrire Int. 2012 Feb;21(124):42-3.

PMID:
22413719
10.

Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.

Ismail Z, Syms J, Blumberger D, George TP.

Schizophr Res. 2010 Jun;119(1-3):268. doi: 10.1016/j.schres.2010.01.027. Epub 2010 Feb 23. No abstract available.

PMID:
20178890
11.

Neuropsychiatric adverse events of varenicline: a systematic review of published reports.

Ahmed AI, Ali AN, Kramers C, Härmark LV, Burger DM, Verhoeven WM.

J Clin Psychopharmacol. 2013 Feb;33(1):55-62. doi: 10.1097/JCP.0b013e31827c0117. Review.

PMID:
23277249
12.

Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.

Tonstad S, Davies S, Flammer M, Russ C, Hughes J.

Drug Saf. 2010 Apr 1;33(4):289-301. doi: 10.2165/11319180-000000000-00000.

PMID:
20297861
13.

Varenicline treatment of concurrent alcohol and nicotine dependence in schizophrenia: a randomized, placebo-controlled pilot trial.

Meszaros ZS, Abdul-Malak Y, Dimmock JA, Wang D, Ajagbe TO, Batki SL.

J Clin Psychopharmacol. 2013 Apr;33(2):243-7. doi: 10.1097/JCP.0b013e3182870551.

PMID:
23422399
14.

Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand.

Harrison-Woolrych M, Ashton J.

Drug Saf. 2011 Sep 1;34(9):763-72. doi: 10.2165/11594450-000000000-00000.

PMID:
21830838
15.

A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.

Garza D, Murphy M, Tseng LJ, Riordan HJ, Chatterjee A.

Biol Psychiatry. 2011 Jun 1;69(11):1075-82. doi: 10.1016/j.biopsych.2010.12.005. Epub 2011 Feb 3.

PMID:
21295286
16.

Varenicline efficacy and tolerability in a subject with schizophrenia.

Fatemi SH.

Schizophr Res. 2008 Aug;103(1-3):328-9. doi: 10.1016/j.schres.2008.05.002. Epub 2008 Jun 24. No abstract available.

PMID:
18572388
17.

Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.

Liu ME, Tsai SJ, Jeang SY, Peng SL, Wu SL, Chen MC, Tsai YL, Yang ST.

Psychiatry Res. 2011 Nov 30;190(1):79-84. doi: 10.1016/j.psychres.2011.04.018. Epub 2011 Jun 1.

PMID:
21636135
18.

Varenicline in smoking cessation.

Tonstad S, Rollema H.

Expert Rev Respir Med. 2010 Jun;4(3):291-9. doi: 10.1586/ers.10.27. Review.

PMID:
20524911
19.

[Effectiveness and safety of varenicline for smoking cessation].

Christalla P, Dewenter M, El-Armouche A.

Dtsch Med Wochenschr. 2012 May;137(18):940-4. doi: 10.1055/s-0032-1304895. Epub 2012 Apr 10. Review. German.

PMID:
22492478
20.

[On oral medications, especially varenicline].

Kurioka N.

Nihon Rinsho. 2013 Mar;71(3):487-92. Review. Japanese.

PMID:
23631241
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk